[96a5a0]: / output / allTrials / identified / NCT01459666_identified.json

Download this file

646 lines (646 with data), 29.7 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
{
"info": {
"nct_id": "NCT01459666",
"official_title": "A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of AbobotulinumtoxinA (BTX-A) in Improving Forehead Wounds After Mohs Micrographic Surgery and Reconstruction for Skin Cancer",
"inclusion_criteria": "Patients must meet all of the following inclusion criteria to be eligible for enrollment:\n\n* Ability to understand the risks, benefits, and alternative to participation and give informed consent\n* Have biopsy proven skin cancer on the medial forehead that is amenable to Mohs surgery. Medial forehead is defined as the area superiorly from the hairline, inferiorly at the eyebrow, and laterally to the tip of the lateral brow (see diagram).\n* Undergoing elective reconstruction of biopsy proven skin cancer that is amenable to Mohs surgery with defect size measuring 1.0 cm or greater\n* If female, not currently pregnant, no potential for pregnancy, or if of child-bearing age, must agree to use adequate contraception (e.g., hormonal or barrier method of birth control; abstinence) for 30 days after the last dose of study drug. A negative urine pregnancy test is required at study entry for female subjects of childbearing potential: a woman is considered to be of child bearing potential unless she has had a tubal ligation, total hysterectomy, bilateral oopherectomy, or is postmenopausal (without a menstrual period for at least one year)\n* Agrees to not use disallowed concomitant medications (retinoids)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "The presence of any of the following will exclude a patient from study enrollment.\n\n* Pregnant women, women who are breastfeeding, or women of child bearing age who are unwilling to use adequate contraception (described above) during the study period\n* Current or past history of a neuromuscular disease (such as myasthenia gravis, amyotrophic lateral sclerosis, Eaton-Lambert syndrome)\n* Currently taking aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like agents)\n* History of radiation therapy or chemotherapy\n* History of keloid or other hypertrophic scar formation\n* Current or past history of scleroderma\n* Has used botulinum toxin in the forehead area within one year.\n* Has significant resting eyebrow ptosis\n* Has used any topical retinoids to the forehead area within the past 4 weeks\n* Undergo any scar revision procedure for the duration of the study including intralesional kenalog, laser treatment, and/or scar revision surgeries\n* Any hypersensitivity to any component of abobotulinumtoxinA (i.e. cow milk protein) or any previous hypersensitivity to any botulinum toxin A or related product.\n* Non-English speaking: These patients are excluded since translation of the informed consent into other languages is time-consuming and expensive as it requires a bona fide translator for the particular language of interest and this type of person may be difficult to locate.\n* House staff and students, medical students on a clerkship, and employees related to study personnel or who work for any study personnel, and members of the study team are not eligible to participate in this study as a subject.\n* The investigator feels that for any reason the subject is not eligible to participate in the study",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Ability to understand the risks, benefits, and alternative to participation and give informed consent",
"criterions": [
{
"exact_snippets": "Ability to understand the risks, benefits, and alternative to participation",
"criterion": "understanding of trial information",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "give informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Have biopsy proven skin cancer on the medial forehead that is amenable to Mohs surgery. Medial forehead is defined as the area superiorly from the hairline, inferiorly at the eyebrow, and laterally to the tip of the lateral brow (see diagram).",
"criterions": [
{
"exact_snippets": "biopsy proven skin cancer",
"criterion": "skin cancer",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": "biopsy proven"
}
]
},
{
"exact_snippets": "medial forehead",
"criterion": "location of skin cancer",
"requirements": [
{
"requirement_type": "specific location",
"expected_value": "medial forehead"
}
]
},
{
"exact_snippets": "amenable to Mohs surgery",
"criterion": "suitability for Mohs surgery",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": true
}
]
}
]
},
{
"line": "* Undergoing elective reconstruction of biopsy proven skin cancer that is amenable to Mohs surgery with defect size measuring 1.0 cm or greater",
"criterions": [
{
"exact_snippets": "Undergoing elective reconstruction",
"criterion": "elective reconstruction",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "biopsy proven skin cancer",
"criterion": "biopsy proven skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "amenable to Mohs surgery",
"criterion": "amenability to Mohs surgery",
"requirements": [
{
"requirement_type": "amenability",
"expected_value": true
}
]
},
{
"exact_snippets": "defect size measuring 1.0 cm or greater",
"criterion": "defect size",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 1.0,
"unit": "cm"
}
}
]
}
]
},
{
"line": "* If female, not currently pregnant, no potential for pregnancy, or if of child-bearing age, must agree to use adequate contraception (e.g., hormonal or barrier method of birth control; abstinence) for 30 days after the last dose of study drug. A negative urine pregnancy test is required at study entry for female subjects of childbearing potential: a woman is considered to be of child bearing potential unless she has had a tubal ligation, total hysterectomy, bilateral oopherectomy, or is postmenopausal (without a menstrual period for at least one year)",
"criterions": [
{
"exact_snippets": "female, not currently pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "no potential for pregnancy",
"criterion": "potential for pregnancy",
"requirements": [
{
"requirement_type": "potential",
"expected_value": false
}
]
},
{
"exact_snippets": "if of child-bearing age, must agree to use adequate contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
},
{
"exact_snippets": "A negative urine pregnancy test is required at study entry for female subjects of childbearing potential",
"criterion": "urine pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "a woman is considered to be of child bearing potential unless she has had a tubal ligation, total hysterectomy, bilateral oopherectomy, or is postmenopausal (without a menstrual period for at least one year)",
"criterion": "childbearing potential",
"requirements": [
{
"requirement_type": "status",
"expected_value": true
}
]
}
]
},
{
"line": "* Agrees to not use disallowed concomitant medications (retinoids)",
"criterions": [
{
"exact_snippets": "not use disallowed concomitant medications (retinoids)",
"criterion": "use of concomitant medications",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
},
{
"requirement_type": "type",
"expected_value": "retinoids"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "The presence of any of the following will exclude a patient from study enrollment.",
"criterions": [
{
"exact_snippets": "The presence of any of the following will exclude a patient from study enrollment.",
"criterion": "exclusion criteria",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnant women, women who are breastfeeding, or women of child bearing age who are unwilling to use adequate contraception (described above) during the study period",
"criterions": [
{
"exact_snippets": "Pregnant women",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "women who are breastfeeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "women of child bearing age who are unwilling to use adequate contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
},
{
"line": "* Current or past history of a neuromuscular disease (such as myasthenia gravis, amyotrophic lateral sclerosis, Eaton-Lambert syndrome)",
"criterions": [
{
"exact_snippets": "Current or past history of a neuromuscular disease",
"criterion": "neuromuscular disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "myasthenia gravis",
"criterion": "myasthenia gravis",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "amyotrophic lateral sclerosis",
"criterion": "amyotrophic lateral sclerosis",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "Eaton-Lambert syndrome",
"criterion": "Eaton-Lambert syndrome",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Currently taking aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like agents)",
"criterions": [
{
"exact_snippets": "Currently taking aminoglycosides",
"criterion": "aminoglycosides usage",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "other agents interfering with neuromuscular transmission (e.g., curare-like agents)",
"criterion": "agents interfering with neuromuscular transmission",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* History of radiation therapy or chemotherapy",
"criterions": [
{
"exact_snippets": "History of radiation therapy",
"criterion": "radiation therapy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "History of ... chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* History of keloid or other hypertrophic scar formation",
"criterions": [
{
"exact_snippets": "History of keloid",
"criterion": "keloid formation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "other hypertrophic scar formation",
"criterion": "hypertrophic scar formation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Current or past history of scleroderma",
"criterions": [
{
"exact_snippets": "Current or past history of scleroderma",
"criterion": "scleroderma",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Has used botulinum toxin in the forehead area within one year.",
"criterions": [
{
"exact_snippets": "Has used botulinum toxin in the forehead area within one year.",
"criterion": "botulinum toxin use in forehead area",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "year"
}
}
]
}
]
},
{
"line": "* Has significant resting eyebrow ptosis",
"criterions": [
{
"exact_snippets": "significant resting eyebrow ptosis",
"criterion": "eyebrow ptosis",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
},
{
"requirement_type": "state",
"expected_value": "resting"
}
]
}
]
},
{
"line": "* Has used any topical retinoids to the forehead area within the past 4 weeks",
"criterions": [
{
"exact_snippets": "Has used any topical retinoids to the forehead area within the past 4 weeks",
"criterion": "topical retinoids use",
"requirements": [
{
"requirement_type": "location",
"expected_value": "forehead area"
},
{
"requirement_type": "time frame",
"expected_value": "past 4 weeks"
}
]
}
]
},
{
"line": "* Undergo any scar revision procedure for the duration of the study including intralesional kenalog, laser treatment, and/or scar revision surgeries",
"criterions": [
{
"exact_snippets": "Undergo any scar revision procedure",
"criterion": "scar revision procedure",
"requirements": [
{
"requirement_type": "undergo",
"expected_value": true
}
]
},
{
"exact_snippets": "intralesional kenalog",
"criterion": "intralesional kenalog",
"requirements": [
{
"requirement_type": "undergo",
"expected_value": true
}
]
},
{
"exact_snippets": "laser treatment",
"criterion": "laser treatment",
"requirements": [
{
"requirement_type": "undergo",
"expected_value": true
}
]
},
{
"exact_snippets": "scar revision surgeries",
"criterion": "scar revision surgeries",
"requirements": [
{
"requirement_type": "undergo",
"expected_value": true
}
]
}
]
},
{
"line": "* Any hypersensitivity to any component of abobotulinumtoxinA (i.e. cow milk protein) or any previous hypersensitivity to any botulinum toxin A or related product.",
"criterions": [
{
"exact_snippets": "hypersensitivity to any component of abobotulinumtoxinA",
"criterion": "hypersensitivity to abobotulinumtoxinA components",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "hypersensitivity to any component of abobotulinumtoxinA (i.e. cow milk protein)",
"criterion": "hypersensitivity to cow milk protein",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "previous hypersensitivity to any botulinum toxin A or related product",
"criterion": "hypersensitivity to botulinum toxin A or related product",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Non-English speaking: These patients are excluded since translation of the informed consent into other languages is time-consuming and expensive as it requires a bona fide translator for the particular language of interest and this type of person may be difficult to locate.",
"criterions": [
{
"exact_snippets": "Non-English speaking: These patients are excluded",
"criterion": "language proficiency",
"requirements": [
{
"requirement_type": "language",
"expected_value": "English"
}
]
}
]
},
{
"line": "* House staff and students, medical students on a clerkship, and employees related to study personnel or who work for any study personnel, and members of the study team are not eligible to participate in this study as a subject.",
"criterions": [
{
"exact_snippets": "House staff ... are not eligible",
"criterion": "house staff",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
},
{
"exact_snippets": "students, medical students on a clerkship ... are not eligible",
"criterion": "students",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
},
{
"exact_snippets": "employees related to study personnel ... are not eligible",
"criterion": "employees related to study personnel",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
},
{
"exact_snippets": "employees ... who work for any study personnel ... are not eligible",
"criterion": "employees who work for study personnel",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
},
{
"exact_snippets": "members of the study team are not eligible",
"criterion": "members of the study team",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
}
]
},
{
"line": "* The investigator feels that for any reason the subject is not eligible to participate in the study",
"criterions": [
{
"exact_snippets": "The investigator feels that for any reason the subject is not eligible to participate in the study",
"criterion": "investigator's discretion",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "Patients must meet all of the following inclusion criteria to be eligible for enrollment:",
"criterions": []
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}